Edition:
United Kingdom

Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

3.40USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$3.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
239,777
52-wk High
$3.93
52-wk Low
$1.59

Select another date:

Mon, Oct 1 2018

Antares Pharma's testosterone drug gets FDA approval

The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected.

UPDATE 1-Antares Pharma's testosterone drug gets FDA approval

Oct 1 The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected.

Antares Pharma's testosterone drug gets FDA approval

Oct 1 The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's drug to treat low testosterone levels in men, the company said, nearly a year after rejecting the injection.

MEDIA-Russia to supply U.S. with new rocket engines - Kommersant

* Russian engine maker Energomash has signed a new contract to supply four RD-181 rocket engines to U.S. aerospace firm Orbital ATK by 2021 for its Antares rocket, the Kommersant newspaper wrote on Tuesday.

BRIEF-Antares Pharma Reports Q1 Loss Per Share Of $0.04

* ANTARES PHARMA REPORTS FIRST QUARTER 2018 OPERATING AND FINANCIAL RESULTS

Select another date: